Evidence map›Paper›PMID 28961172›Full record

ArticleViruses2017

A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa.

Siv Aina J Leendertz, Daniel Stern, Dennis Theophil, Etile Anoh, Arsène Mossoun, Grit Schubert, Lidewij Wiersma, Chantal Akoua-Koffi, Emmanuel Couacy-Hymann, Jean-Jacques Muyembe-Tamfum and 5 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Does it matter who is spreading monkeypox?The Lancet. Infectious diseases · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Modelling human-to-human transmission of monkeypox.Bulletin of the World Health Organization · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Siv Aina J LeendertzEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, 13353 Berlin, Germany. LeendertzS@rki.de.
Daniel SternCentre for Biological Threats and Special Pathogens ZBS 1, Highly Pathogenic Viruses Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353 Berlin, Germany. SternD@rki.de.ORCID 0000-0001-9057-4283
Dennis TheophilCentre for Biological Threats and Special Pathogens ZBS 1, Highly Pathogenic Viruses Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353 Berlin, Germany. Theokom@gmx.net.
Etile AnohUniversité Felix Houphouët Boigny, Abidjan BP 1174, Cote D'Ivoire. anohethyl@yahoo.fr.
Arsène MossounUniversité Felix Houphouët Boigny, Abidjan BP 1174, Cote D'Ivoire. mossouna@yahoo.fr.
Grit SchubertEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, 13353 Berlin, Germany. SchubertG@rki.de.
Lidewij WiersmaEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, 13353 Berlin, Germany. Lidewij.Wiersma@fao.org.
Chantal Akoua-KoffiCentre de Recherche pour le Développement, Université Alassane Ouattara, Bouaké BP 1174, Cote D'Ivoire. Akouamc@yahoo.fr.
Emmanuel Couacy-HymannLaboratoire National D'appui au Développement Agricole/Laboratoire Central de Pathologie Animale, Bingerville BP 206, Cote D'Ivoire. chymann@hotmail.com.
Jean-Jacques Muyembe-TamfumInstitut National de Recherche Biomédicale, Kinshasa BP 1197, Democratic Republic of the Congo. jjmuyembet@gmail.com.
Stomy KarhemereInstitut National de Recherche Biomédicale, Kinshasa BP 1197, Democratic Republic of the Congo. Stomy.Karhemere@inrb.cd.
Maude PaulyEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, 13353 Berlin, Germany. Maude.Pauly@lih.lu.
Livia SchrickCentre for Biological Threats and Special Pathogens ZBS 1, Highly Pathogenic Viruses Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353 Berlin, Germany. SchrickL@rki.de.
Fabian H LeendertzEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, 13353 Berlin, Germany. LeendertzF@rki.de.
Andreas NitscheCentre for Biological Threats and Special Pathogens ZBS 1, Highly Pathogenic Viruses Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353 Berlin, Germany. nitschea@rki.de.
Robert Koch Institute · DELaboratoire National d'Appui au Développement Agricole · CINational Institute of Biomedical Research · CDUniversité Alassane Ouattara · CI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the eradication of smallpox and the subsequent discontinuation of the worldwide smallpox vaccination program, other Orthopoxviruses beside Variola virus have been increasingly representing a risk to human health. To investigate the extent of natural contact with Orthopoxviruses and possible demographic risk factors for such an exposure, we performed a cross-sectional serosurvey of anti-Orthopoxvirus IgG antibodies in West and Central Africa. To this end, people living in forest regions in Côte d'Ivoire (CIV,

Indexed as

Seroepidemiologic StudiesAdolescentAdultAgedAged, 80 and overAnimalsAntibodies, ViralChildCote d'IvoireCross-Sectional StudiesDemocratic Republic of the CongoEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GLogistic ModelsAntibodies, ViralImmunoglobulin GSmallpox VaccineELISA (enzyme linked immunosorbent assay)orthopoxvirusseroprevalencezoonoses

Identifiers

PMID28961172
PMCPMC5691630
OpenAlexW2759843597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.